Data protection Impressum

Financing

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (March 2026)

1 April 2026

miros, an EPFL ecosystem start-up developing a network of bookable connected workpods, has closed a CHF 1 million pre-seed round to scale its deployment across Switzerland, targeting over 100 units by end of 2026.

miros raises CHF 1 million to deploy a national network of connected workpods

31 March 2026

SolidWatts has closed a CHF 1.8 million seed round to accelerate the development and market entry of its solid-state Radio Frequency heating platform, targeting the electrification of energy-intensive industrial processes.

SolidWatts raises CHF 1.8 million to scale its RF industrial heating platform

30 March 2026

The Foundation for Innovation and Technology (FIT) has awarded Tech Seed loans totaling CHF 250,000 to three Western Switzerland start-ups developing solutions in therapeutic gaming, pregnancy monitoring, and sports protection.

FIT awards Tech Seed loans to Diverssity, MoleSense, and Performance MouthGuard

23 March 2026

Rhonexum, an EPFL spin-out developing electronics for cryogenic environments, has raised USD 1 million in pre-seed funding to accelerate product development and deliver its first industrial-grade cryogenic electronics solution to early customers.

Rhonexum raises USD 1 million to advance cryogenic electronics for quantum computing

23 March 2026

Seprify has raised CHF 12.25 million in Series A funding to transition its cellulose platform from pilot validation into industrial-scale supply across cosmetics, food, and coatings markets.

Seprify raises CHF 12.25 million to scale its cellulose-based materials platform

11 March 2026

Lausanne-based Polares Medical has closed an oversubscribed USD 50 million Series C financing round to advance clinical studies of its MRace Posterior Leaflet Replacement system for mitral regurgitation across the US, Europe, and Australia.

Polares Medical raises USD 50 million to advance its mitral valve replacement system

9 March 2026

Alithea Genomics has completed its seed financing round with an additional CHF 3 million, bringing the total to CHF 6.9 million, to accelerate the commercialization of its large-scale RNA sequencing platforms for drug screening and toxicology.

Alithea Genomics raises CHF 6.9 million to industrialize RNA sequencing

9 March 2026

As life sciences companies navigate increasingly complex global markets, the decision of where to establish or expand international operations has become a strategic one.

Why Life Sciences Companies Choose Switzerland to Scale Internationally

Lausanne-based Xsensio has closed an oversubscribed USD 7 million Series A financing round to accelerate clinical deployment of its Lab-on-Skin wearable biosensing platform, with new backing from WI Harper and a collaboration with Texas Instruments.

Xsensio raises USD 7 million to advance its wearable biosensing platform

3 March 2026

1 2 3 4 5 6 7 8 9 … 32